首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

微陣列分析市場規模、佔有率及成長分析（按產品、類型、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900650

微陣列分析市場規模、佔有率及成長分析（按產品、類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Microarray Analysis Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Type (DNA Microarray, Protein Microarray), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，微陣列分析市場規模將達到 39.9 億美元，到 2025 年將達到 43.1 億美元，到 2033 年將達到 79.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.9%。

微陣列分析市場是生物技術產業中一個充滿活力的領域，專注於利用高通量技術分析基因表現和遺傳變異。個人化醫療需求的不斷成長、基因組學研究的進步以及慢性病發病率的上升是推動該市場成長的主要因素。此市場應用廣泛，包括基因表現分析、基因型鑒定、表觀遺傳學和生物標記發現。微陣列技術革新了基因組學和分子生物學，使研究人員能夠探索廣泛的基因表現模式、識別疾病相關基因並輔助藥物研發。與次世代定序和生物資訊學的協同作用進一步提升了其市場潛力。儘管北美憑藉其完善的研究基礎設施繼續主導市場，但亞太地區對精準醫療日益成長的關注正在推動市場進一步擴張和創新。

微陣列分析市場促進因素

推動微陣列分析市場發展的關鍵因素是日益成長的個人化醫療需求。個人化醫療著重根據個人獨特的基因譜客製化醫療方案，從而提高治療的準確性和有效性。微陣列分析在這一過程中至關重要，因為它能夠提供豐富的基因組資訊，並有助於識別與特定疾病相關的基因突變。隨著全球醫療機構加速採用個人化醫療策略，對先進微陣列分析技術的需求不斷成長，推動了基因研究和診斷領域的市場成長和創新。

微陣列分析市場限制因素

微陣列分析市場面臨的主要挑戰之一是微陣列技術及相關分析的高成本。平台、試劑和設備的成本可能非常高昂，限制了預算有限的研究機構和醫療機構的使用。此外，數據分析的複雜性和對專業知識的需求也加重了整體經濟負擔。這些高成本可能會阻礙資源匱乏地區對微陣列技術的廣泛應用，進而抑制市場成長。為了解決這個問題，必須努力透過技術創新和更有效率的工作流程來降低成本，使其更加經濟實惠，從而提高市場滲透率。

微陣列分析市場趨勢

微陣列分析市場的一個顯著趨勢是微陣列技術與其他體學平台（例如次世代定序(NGS) 和先進的生物資訊學工具）的融合。這種融合使得研究人員能夠從多方面探索生物數據，從而整體情況了解基因組、轉錄組和表觀基因。將微陣列數據與 NGS 數據結合，能夠幫助科學家更深入地了解基因表現模式和遺傳變異，進而改善疾病建模並推動個人化醫療的發展。這一趨勢表明，全面的分子譜分析日益重要，並推動了相關技術的創新，從而產生更豐富、更實用價值的數據，以期能更好地理解複雜的生物學現象。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Illumina, Inc.（United States）
Agilent Technologies, Inc.（United States）
Thermo Fisher Scientific, Inc.（United States）
Merck KGaA（Germany）
PerkinElmer, Inc.（United States）
Arrayit Corporation（United States）
Bio-Rad Laboratories, Inc.（United States）
GE Healthcare（United States）
Molecular Devices, LLC.（United States）
Affymetrix（United States）
Applied Microarrays, Inc.（United States）
Oxford Gene Technology（United Kingdom）
CapitalBio Corporation（China）
Macrogen, Inc.（South Korea）
LC Sciences（United States）
Scienion AG（Germany）
Arrayjet Ltd.（United Kingdom）
RayBiotech, Inc.（United States）
Genotypic Technology Pvt. Ltd.（India）
Microarrays Inc.（United States）

結論與建議

簡介目錄

Product Code: SQMIG35J2057

Microarray Analysis Market size was valued at USD 3.99 Billion in 2024 and is poised to grow from USD 4.31 Billion in 2025 to USD 7.91 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The Microarray Analysis Market is a dynamic segment of the biotechnology industry, focused on high-throughput techniques for analyzing gene expression and genetic variations. This growth is propelled by the rising demand for personalized medicine, advancements in genomic research, and the increasing incidence of chronic diseases. The market offers diverse applications, including gene expression profiling, genotyping, epigenetics, and biomarker discovery. Microarray technologies have transformed genomics and molecular biology, allowing researchers to explore extensive gene expression patterns, identify disease-related genes, and support drug development. The synergy with next-generation sequencing and bioinformatics enhances its market potential. While North America remains a leader due to established research infrastructure, the Asia-Pacific region is emerging with a growing emphasis on precision medicine, driving further market expansion and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microarray Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microarray Analysis Market Segments Analysis

Global Microarray Analysis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Type, the market is segmented into DNA Microarray, Protein Microarray and Others. Based on Application, the market is segmented into Rese arch Applications, Drug Discovery, Disease Diagnostics and Others Applications. Based on End User, the market is segmented into Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Microarray Analysis Market

A significant factor propelling the Microarray Analysis market is the rising demand for personalized medicine. This approach focuses on customizing medical treatments to suit the unique genetic profiles of individuals, thereby enhancing the precision and efficacy of therapies. Microarray analysis is integral to this process, as it delivers extensive genomic insights and helps identify genetic variations linked to specific diseases. As healthcare providers increasingly adopt personalized medicine strategies globally, the need for advanced microarray analysis techniques is expanding, subsequently driving market growth and innovation in the field of genetic research and diagnostics.

Restraints in the Microarray Analysis Market

A significant challenge facing the Microarray Analysis market is the considerable expenses linked to microarray technologies and their associated analyses. The cost of platforms, reagents, and instruments can be prohibitively high, limiting access for some research institutions and healthcare facilities with constrained budgets. Moreover, the intricate nature of data analysis and the necessity for specialized knowledge also contribute to the overall financial burden. These high costs can deter widespread adoption in resource-limited environments, thus stifling market growth. To address this issue, initiatives aimed at reducing costs and enhancing affordability through technological innovations and more efficient workflows are essential for fostering greater market penetration.

Market Trends of the Microarray Analysis Market

A prominent trend in the Microarray Analysis Market is the convergence of microarray technology with other omics platforms, such as next-generation sequencing (NGS) and advanced bioinformatics tools. This integration facilitates a multi-faceted exploration of biological data, enabling researchers to gain a holistic understanding of genomic, transcriptomic, and epigenomic landscapes. By harmonizing microarray data with NGS, scientists can achieve deeper insights into gene expression patterns and genetic variations, thereby enhancing the precision of disease modeling and personalizing medical treatments. This trend underscores the growing emphasis on comprehensive molecular profiling, driving innovations that yield richer, more actionable data in the quest to unravel complex biological phenomena.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Microarray Analysis Market Size by Product & Services & CAGR (2026-2033)

Market Overview
Consumables
Instruments
Software
Services

Global Microarray Analysis Market Size by Type & CAGR (2026-2033)

Market Overview
DNA Microarray
Protein Microarray
Others

Global Microarray Analysis Market Size by Application & CAGR (2026-2033)

Market Overview
Research Applications
Drug Discovery
Disease Diagnostics
Others Applications

Global Microarray Analysis Market Size by End User & CAGR (2026-2033)

Market Overview
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Others

Global Microarray Analysis Market Size & CAGR (2026-2033)

North America (Product & Services, Type, Application, End User)
- US
- Canada
Europe (Product & Services, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Services, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Services, Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Services, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayit Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Affymetrix (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Microarrays, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Gene Technology (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macrogen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LC Sciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Scienion AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayjet Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genotypic Technology Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microarrays Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments